Home
>
US Stocks
>
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc
MDGL

Madrigal Pharmaceuticals Inc (MDGL)

$78.473.93%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
77.96
Today Low/High
75.92 / 78.47
52 Week Low/High
$81.52 / $142.62
Market Cap
$1.37B

Company Details

Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need. Madrigal recognizes that compounds with greater selectivity for thyroid hormone receptor (THR)-ß and liver uptake has the greatest potential to overcome challenges faced by prior, less selective compounds and deliver the full therapeutic potential of THR-ß agonism. The Company believes that resmetirom, its lead product candidate, is the first orally administered, small-molecule, liver-directed, truly ß-selective THR agonist.
Organisation
Madrigal Pharmaceuticals Inc
Headquaters
Fort Washington, Pennsylvania, US
Employees
42
Industry
Health Technology
CEO
Rebecca Taub

Discover more

Frequently Asked Questions

What is Madrigal Pharmaceuticals Inc (MDGL) share price today?

Can Indians buy Madrigal Pharmaceuticals Inc (MDGL) shares?

How can I buy Madrigal Pharmaceuticals Inc (MDGL) shares from India?

Can Fractional shares of Madrigal Pharmaceuticals Inc (MDGL) be purchased?

What are the documents required to start investing in Madrigal Pharmaceuticals Inc (MDGL) stocks?

We are a SEBI registered investement advisor